Tokyo, July 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058395) titled 'Prediction of chemosensitivity testing for clinical efficacy with patient-derived cancer stem cells; an observational study' on July 7.
Study Type:
Observational
Primary Sponsor:
Institute - Kyoto University
Condition:
Condition - Colorectal cancer
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - We are developing a research protocol for a drug sensitivity test method that can best predict the therapeutic effect of chemotherapy regimens including irinotecan in actual clinical practice for patients using an in vitro model established by culturing patient-derived...